Zhaohui (Vincent) Wang, Ph.D.

Vincent Wang serves as the manager of the University of Texas Southwestern Medical Center Next Generation Sequencing Clinical Laboratory.

He obtained his PhD in Biomedical Science from University of North Texas. After graduation, he joined Gradalis and participated and led multiple projects on developing RNA interference-based gene therapeutics. In 2016, he started to work for UTSW’s Molecular Diagnostics lab and was responsible for developing molecular tests to support clinical testing. He joined the Once Upon a Time Human Genomics Center in July 2022.

Key Publications

Clark AE, Wang Z, Ostman E, Zheng H, Yao H, Cantarel B, Kanchwala M, Xing C, Chen L, Irwin P, Xu Y, Oliver D, Lee FM, Gagan JR, Filkins L, Muthukumar A, Park JY, Sarode R, SoRelle JA. Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern. Clin Chem. 2022 Jul 27;68(8):1042-1052. PMID: 35616102.

Wang Z, Jay CM, Evans C, Kumar P, Phalon C, Rao DD, Senzer N, Nemunaitis J. Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous Delivery. Toxicol Sci. 2017 Feb;155(2):400-408. PMID: 27815492.

Barve M, Wang Z, Kumar P, Jay CM, Luo X, Bedell C, Mennel RG, Wallraven G, Brunicardi FC, Senzer N, Nemunaitis J, Rao DD. Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer. Mol Ther. 2015 Jun;23(6):1123-1130. PMID: 25619726.

Wang Z, Rao DD, Senzer N, Nemunaitis J. RNA interference and cancer therapy. Pharm Res. 2011 Dec;28(12):2983-95. PMID: 22009588.